Latest news
pDC-AML: consider early allogeneic HSCT to offset poor prognosis - Vera HealthVera Health · Mon, 03 Aug 2026 19:38:51 GMTLate complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european - NatureNature · Mon, 27 Jul 2026 16:42:15 GMTAstraZeneca’s HSCT-TMA drug misses main endpoint - EMJEMJ · Mon, 27 Jul 2026 14:52:19 GMTUltomiris fails to beat placebo in adult HSCT-TMA trial, narrowing approval path to children - AllSciAllSci · Mon, 27 Jul 2026 11:28:04 GMTMixed Ultomiris HSCT-TMA results at AstraZeneca (NASDAQ: AZN) spur paediatric filings - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT